Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update
Tsipora M Huisman, Douglas T Dieterich, Scott L Friedman Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: Scott L FriedmanIcahn School of Medicine at Mount Sinai, Box 1123, 1425 Madison Ave, Room 1170C, New York, NY, 10025, USAEmail Scott.friedman...
Saved in:
Main Authors: | Huisman TM (Author), Dieterich DT (Author), Friedman SL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imaging biomarkers of NAFLD, NASH, and fibrosis
by: Veeral Ajmera, et al.
Published: (2021) -
Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients
by: Mona Hegazy, et al.
Published: (2012) -
Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH
by: David Montefusco, et al.
Published: (2022) -
NAShI AVTORY
by: -
Published: (2016) -
NAShI AVTORY
by: -
Published: (2015)